Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Batalla

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Acta Dermato-Venereologica|December 11, 2023
Off-label Prescription in Paediatric Dermatology: A Retrospective Observational Study in a Tertiary HospitalCarmen Couselo-Rodríguez, Ana Batalla, Sandra Martínez-Fernández, et al.
Healthcare (Basel, Switzerland)|January 26, 2024
Dermatology Self-Medication in Nursing Students and Professionals: A Multicentre StudyAna Batalla, Alba-Elena Martínez-Santos, Sara Braña Balige, et al.
Archives of Dermatological Research|December 25, 2014
The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patientsLeire González-Lara, Ana Batalla, Eliecer Coto, et al.
Pharmacogenetics and Genomics|March 21, 2015
The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patientsAna Batalla, Eliecer Coto, Daniel González-Fernández, et al.
International Journal of Dermatology|May 15, 2025
Rowell Syndrome: A Controversial EntityCarmen Cánovas Seva, Ana Batalla, Jose Ramón Maneiro Fernández, et al.
International Immunopharmacology|November 14, 2015
CDKAL1 gene variants affect the anti-TNF response among Psoriasis patientsPablo Coto-Segura, Ana Batalla, Daniel González-Fernández, et al.
Journal of the American Academy of Dermatology|July 18, 2015
Cardiovascular risk factors influence response to biological therapies in psoriasisAna Batalla, Daniel González-Fernández, Leire González-Lara, et al.
Journal of Drugs in Dermatology : JDD|February 4, 2021
Hospitalization in Patients with Psoriasis: Impact of Biological Therapies on Temporal EvolutionQueila Rodriguez-Jato, Alessia Ruibal Pereira, Ana Batalla, et al.
Human Immunology|February 1, 2015
Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohortEliecer Coto, Juan Gómez, Beatriz Suárez, et al.
Human Immunology|March 6, 2017
NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variantPablo Coto-Segura, Leire Gonzalez-Lara, Juan Gómez, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Acta Dermato-Venereologica|December 11, 2023
Off-label Prescription in Paediatric Dermatology: A Retrospective Observational Study in a Tertiary HospitalCarmen Couselo-Rodríguez, Ana Batalla, Sandra Martínez-Fernández, et al.
Healthcare (Basel, Switzerland)|January 26, 2024
Dermatology Self-Medication in Nursing Students and Professionals: A Multicentre StudyAna Batalla, Alba-Elena Martínez-Santos, Sara Braña Balige, et al.
Archives of Dermatological Research|December 25, 2014
The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patientsLeire González-Lara, Ana Batalla, Eliecer Coto, et al.
Pharmacogenetics and Genomics|March 21, 2015
The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patientsAna Batalla, Eliecer Coto, Daniel González-Fernández, et al.
International Journal of Dermatology|May 15, 2025
Rowell Syndrome: A Controversial EntityCarmen Cánovas Seva, Ana Batalla, Jose Ramón Maneiro Fernández, et al.
International Immunopharmacology|November 14, 2015
CDKAL1 gene variants affect the anti-TNF response among Psoriasis patientsPablo Coto-Segura, Ana Batalla, Daniel González-Fernández, et al.
Journal of the American Academy of Dermatology|July 18, 2015
Cardiovascular risk factors influence response to biological therapies in psoriasisAna Batalla, Daniel González-Fernández, Leire González-Lara, et al.
Journal of Drugs in Dermatology : JDD|February 4, 2021
Hospitalization in Patients with Psoriasis: Impact of Biological Therapies on Temporal EvolutionQueila Rodriguez-Jato, Alessia Ruibal Pereira, Ana Batalla, et al.
Human Immunology|February 1, 2015
Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohortEliecer Coto, Juan Gómez, Beatriz Suárez, et al.
Human Immunology|March 6, 2017
NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variantPablo Coto-Segura, Leire Gonzalez-Lara, Juan Gómez, et al.
Pageof 6